Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Abdominal Pain in Clostridioides difficile Infection

Clinical Presentation

  • Abdominal pain in CDI is typically accompanied by diarrhea, which is the hallmark symptom, though pain may occasionally precede the onset of diarrhea 1, 2
  • Pain is usually diffuse and located in the lower abdomen, corresponding to colonic inflammation 2
  • The severity of abdominal pain often correlates with the severity of the infection 2
  • In severe cases, abdominal pain may be accompanied by abdominal distension, tenderness, and decreased bowel sounds, which can signal progression to toxic megacolon or ileus 1, 2

Risk Factors

  • Patients with age ≥65 years are more likely to experience severe abdominal pain with CDI 3, 4
  • Leukocytosis (elevated white blood cell count) is a risk factor for more severe abdominal pain 2
  • Hypoalbuminemia (low albumin levels) is a risk factor for more severe abdominal pain 2
  • Recent hospitalization or healthcare facility exposure is a risk factor for more severe abdominal pain 2
  • Recent antibiotic use, especially fluoroquinolones, is a risk factor for more severe abdominal pain 2
  • Immunocompromised status, such as transplant recipients, cancer patients, or HIV/AIDS, is a risk factor for more severe abdominal pain 5
  • Inflammatory bowel disease (IBD) is a risk factor for more severe abdominal pain, as patients with IBD have higher risk of severe CDI with more pronounced abdominal pain 5

Diagnostic Considerations

  • Abdominal pain with elevated white blood cell count should strongly suggest CDI even in the absence of diarrhea 4
  • CT imaging may show colonic wall thickening, pericolonic stranding, or ascites in patients with severe CDI and significant abdominal pain 6, 2
  • Perirectal swabs may be an acceptable alternative for CDI testing in patients with severe abdominal pain and ileus who cannot produce stool specimens 1
  • Patients with severe abdominal pain should be tested for C. difficile toxins in stool specimens 1, 4

Management Implications

  • Severe abdominal pain, especially when accompanied by fever, elevated white blood cell count, and hypoalbuminemia, should prompt consideration of oral vancomycin or fidaxomicin rather than metronidazole as first-line therapy 3, 7
  • Patients with severe abdominal pain and signs of ileus or toxic megacolon may require additional vancomycin administered via nasogastric tube and/or rectal catheter 3, 7
  • Early surgical consultation should be obtained for patients with severe abdominal pain, especially those with signs of peritonitis, as they may require colectomy if medical management fails 3, 2
  • Antiperistaltic agents, including opiates, should be avoided in patients with CDI and abdominal pain as they may worsen the clinical course 7